Cellex

Its core business is the development of bioreactors for advanced cell culture and tissue engineering. Cellex is currently focused on the design, development and production of SUSPENCE®, a highly innovative scalable bioreactor that keeps cells in suspension in a culture chamber, allowing them to grow and reach maturity in dynamic conditions. The team responsible for the activities of CELLEX is a highly skilled and deeply experienced technical and commercial team. They are specialists in the field of medical technology, manufacturing, marketing, quality and regulatory management, project management and strategy, business management and communication. Founder and CEO of Cellex, is a Nuclear Engineer, PhD in Biomedical Engineering.